Immunovant (IMVT) Accumulated Expenses (2018 - 2026)
Immunovant (IMVT) recorded Accumulated Expenses of $106.96 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 137.4% from $45.06 million a year earlier and up 10.4% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Accumulated Expenses (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Immunovant reported Accumulated Expenses of $96.88 million, up 90.9% from FY2025.
- Annual Accumulated Expenses has increased for seven straight fiscal years, with a five-year compound annual growth rate of 44.9% (FY2021 to FY2026).
- Across earlier fiscal years, Accumulated Expenses came in at $50.75 million in FY2025 (+22.9%), $41.3 million in FY2024 (+2.2%), $40.42 million in FY2023 (+64.5%) and $24.58 million in FY2022 (+62.1%).
- The fiscal Q1 2027 figure is the highest quarterly Accumulated Expenses in data going back to fiscal Q3 2019.
- On a year-over-year basis, Accumulated Expenses has increased for 14 consecutive quarters, with growth averaging 55.3% over the last eight quarters.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 298.4% in fiscal Q2 2022, against a decline of 17.2% in fiscal Q3 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $96.88 million (Q4 2026), $57.64 million (Q3 2026) and $56.34 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Immunovant | 6.97 Bn | 6.97 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 106.96 Mn |
| Mar 31, 2026 | 96.88 Mn |
| Dec 31, 2025 | 57.64 Mn |
| Sep 30, 2025 | 56.34 Mn |
| Jun 30, 2025 | 45.06 Mn |
| Mar 31, 2025 | 50.75 Mn |
| Dec 31, 2024 | 48.48 Mn |
| Sep 30, 2024 | 45.88 Mn |
| Jun 30, 2024 | 33.91 Mn |
| Mar 31, 2024 | 41.30 Mn |
| Dec 31, 2023 | 27.89 Mn |
| Sep 30, 2023 | 32.13 Mn |
| Jun 30, 2023 | 23.98 Mn |
| Mar 31, 2023 | 40.42 Mn |
| Dec 31, 2022 | 26.05 Mn |
| Sep 30, 2022 | 23.14 Mn |
| Jun 30, 2022 | 19.01 Mn |
| Mar 31, 2022 | 24.58 Mn |
| Dec 31, 2021 | 31.45 Mn |
| Sep 30, 2021 | 23.06 Mn |
API Access
Immunovant Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();